Molecular mechanisms of α-synuclein neurodegeneration

被引:164
作者
Waxman, Elisa A. [1 ]
Giasson, Benoit I. [1 ]
机构
[1] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2009年 / 1792卷 / 07期
关键词
alpha-synuclein; Amyloid; Fibril; Parkinson's disease; Protofibril; Toxicity; MULTIPLE SYSTEM ATROPHY; SOLUBLE AMYLOID OLIGOMERS; BRAIN IRON ACCUMULATION; CHAPERONE-LIKE ACTIVITY; DOPAMINE NEURON DEATH; PARKINSONS-DISEASE; LEWY BODIES; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRANSGENIC MICE;
D O I
10.1016/j.bbadis.2008.09.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein is an abundant highly charged protein that is normally predominantly localized around synaptic vesicles in presynaptic terminals. Although the function of this protein is still ill-defined, genetic studies have demonstrated that point mutations or genetic alteration (duplications or triplications) that increase the number of copies of the alpha-synuclein (SCNA) gene can cause Parkinson's disease or the related disorder dementia with Lewy bodies. alpha-Synuclein can aberrantly polymerize into fibrils with typical amyloid properties, and these fibrils are the major component of many types of pathological inclusions, including Lewy bodies, which are associated with neurodegenerative diseases, such as Parkinson's disease. Although there is substantial evidence supporting the toxic nature of alpha-synuclein inclusions, other modes of toxicity such as oligomers have been proposed. In this review, some of the evidence for the different mechanisms of alpha-synuclein toxicity is presented and discussed. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:616 / 624
页数:9
相关论文
共 169 条
[21]  
Conway KA, 2000, ANN NY ACAD SCI, V920, P42
[22]   α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models [J].
Cooper, Antony A. ;
Gitler, Aaron D. ;
Cashikar, Anil ;
Haynes, Cole M. ;
Hill, Kathryn J. ;
Bhullar, Bhupinder ;
Liu, Kangning ;
Xu, Kexiang ;
Strathearn, Katherine E. ;
Liu, Fang ;
Cao, Songsong ;
Caldwell, Kim A. ;
Caldwell, Guy A. ;
Marsischky, Gerald ;
Kolodner, Richard D. ;
LaBaer, Joshua ;
Rochet, Jean-Christophe ;
Bonini, Nancy M. ;
Lindquist, Susan .
SCIENCE, 2006, 313 (5785) :324-328
[23]   Wild-type but not Parkinson's disease-related Ala-53 → Thr mutant α-synuclein protects neuronal cells from apoptotic stimuli [J].
da Costa, CA ;
Ancolio, K ;
Checler, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :24065-24069
[24]   α-Synuclein lowers p53-dependent apoptotic response of neuronal cells -: Abolishment by 6-hydroxydopamine and implication for Parkinson's disease [J].
da Costa, CA ;
Paitel, E ;
Vincent, B ;
Checler, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (52) :50980-50984
[25]   The ups and downs of α-synuclein mRNA expression [J].
Daechsel, Justus C. ;
Lincoln, Sarah J. ;
Gonzalez, John ;
Ross, Owen A. ;
Dickson, Dennis W. ;
Farrer, Matthew J. .
MOVEMENT DISORDERS, 2007, 22 (02) :293-295
[26]   The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease [J].
Damier, P ;
Hirsch, EC ;
Agid, Y ;
Graybiel, AM .
BRAIN, 1999, 122 :1437-1448
[27]   Stabilization of α-synuclein secondary structure upon binding to synthetic membranes [J].
Davidson, WS ;
Jonas, A ;
Clayton, DF ;
George, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9443-9449
[28]   Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes [J].
Ding, TT ;
Lee, SJ ;
Rochet, JC ;
Lansbury, PT .
BIOCHEMISTRY, 2002, 41 (32) :10209-10217
[29]   Immunohistochemical and biochemical studies demonstrate a distinct profile of α-synuclein permutations in multiple system atrophy [J].
Duda, JE ;
Giasson, BI ;
Gur, TL ;
Montine, TJ ;
Robertson, D ;
Biaggioni, I ;
Hurtig, HI ;
Stern, MB ;
Gollomp, SM ;
Grossman, M ;
Lee, VMY ;
Trojanowski, JQ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (09) :830-841
[30]  
Duda JE, 2003, ANN NY ACAD SCI, V991, P295